<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autocrine secretion of cytokines by <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> cells and their role during invasion and liver homing has been poorly characterized </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we used cytokine arrays to analyze the secretomes of poorly and highly <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with poorly <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e> cells, highly metastatic cells expressed increased levels of the immunosuppressive cytokines interleukin (IL)-4 and IL-13 in addition to increased surface expression of the high affinity IL-13 receptor IL-13Rα2, suggesting that IL-13R��2 mediates IL-13 effects in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Silencing of IL-13Rα2 in highly metastatic cells led to a decrease in <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> capacity in vitro and a reduction in liver homing and increased survival in vivo, revealing a role for this receptor in cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration, invasion, and metastatic colonization </plain></SENT>
<SENT sid="4" pm="."><plain>In support of this, IL-13 signaling activated the oncogenic signaling molecules <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 3-kinase, AKT, and SRC in highly metastatic cells </plain></SENT>
<SENT sid="5" pm="."><plain>Clinically, high expression of IL-13Rα2 was associated with later stages of disease progression and poor outcome in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings therefore support a critical role for IL-13Rα2 expression in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>